Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Recruiting 5Active not recruiting 3Unknown 2Terminated 2Not yet recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 704Carcinoma, Non-Small-Cell Lung 470Prostatic Neoplasms 420Neoplasms 380Multiple Myeloma 264Colorectal Neoplasms 261Lung Neoplasms 247Neoplasm Metastasis 229Melanoma 215Ovarian Neoplasms 191Leukemia, Myeloid, Acute 189Pancreatic Neoplasms 182Squamous Cell Carcinoma of Head and Neck 163Recurrence 147Carcinoma, Renal Cell 145Lymphoma 142Glioblastoma 138Lymphoma, Non-Hodgkin 135Stomach Neoplasms 128Triple Negative Breast Neoplasms 127Brain Neoplasms 124Carcinoma, Hepatocellular 123Leukemia, Lymphocytic, Chronic, B-Cell 122Uterine Cervical Neoplasms 117Head and Neck Neoplasms 117Precursor Cell Lymphoblastic Leukemia-Lymphoma 115Urinary Bladder Neoplasms 113Lymphoma, Large B-Cell, Diffuse 105Sarcoma 102Lymphoma, Follicular 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × Advanced Solid Cancer × Clear all
NCT05947474 2026-02-10

ORB

Orionis Biosciences Inc

Phase 1 Active not recruiting
55 enrolled

Advanced Solid Cancer

NCT04877717 2025-03-25

A Study of SHR-A1904 in Patients With Advanced Solid Cancer

Shanghai Hengrui Pharmaceutical Co., Ltd.

Phase 1 Active not recruiting
107 enrolled

Advanced Solid Cancer

NCT03791112 2025-01-27

A Phase I Study of BPI-16350 in Patients with Advanced Solid Tumor

Betta Pharmaceuticals Co., Ltd.

Phase 1 Active not recruiting
54 enrolled

Advanced Solid Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡